Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arvanitakis, Z.
Right arrow Articles by Bennett, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arvanitakis, Z.
Right arrow Articles by Bennett, D. A.
Related Collections
Right arrow Endocrine
Right arrow All Cerebrovascular disease/Stroke
Right arrow Alzheimer's disease
Right arrow Infarction
NEUROLOGY 2006;67:1960-1965
© 2006 American Academy of Neurology

Diabetes is related to cerebral infarction but not to AD pathology in older persons

Z. Arvanitakis, MD, J. A. Schneider, MD, MS, R. S. Wilson, PhD, Y. Li, PhD, S. E. Arnold, MD, Z. Wang, MD and D. A. Bennett, MD

From Rush Alzheimer's Disease Center (Z.A., J.A.S., R.S.W., Z.W., D.A.B.), Department of Neurological Sciences (Z.A., J.A.S., R.S.W., D.A.B.), Department of Pathology (J.A.S.), Department of Behavioral Sciences (R.S.W.), Rush Institute for Healthy Aging (Y.L.), and Department of Internal Medicine (Y.L.), Rush University Medical Center, Chicago, IL; and Center for Neurobiology and Behavior (S.E.A.), University of Pennsylvania, Philadelphia.

Address correspondence and reprint requests to Dr. Zoe Arvanitakis, Rush Alzheimer's Disease Center, 600 S. Paulina, Suite 1020, Rush University Medical Center, Chicago, IL 60612.

Objective: To examine the potential relation of diabetes to common neuropathologic causes of dementia, cerebral infarction and Alzheimer disease (AD) neuropathology.

Methods: Subjects were 233 older Catholic clergy in the Religious Orders Study, who underwent detailed annual evaluations, including neuropsychological testing, and brain autopsy at time of death (mean age 86 years, 45% men). Diabetes was identified by annual direct medication inspection and history. Cognitive function proximate to death was summarized into five cognitive domains, based on 19 neuropsychological tests. Macroscopic cerebral infarctions were recorded from 1 cm coronal slabs. Neuritic plaques, diffuse plaques, and neurofibrillary tangles were counted in Bielschowsky silver-stained sections and summarized to yield composite measures of neuritic plaques, diffuse plaques, tangles, and overall AD pathology. We also used immunohistochemistry with antibodies to amyloid-ß and PHF-tau to obtain quantitative measures of amyloid burden and neurofibrillary tangle density. Multiple logistic and linear regression analyses were used to examine the relation of diabetes to cerebral infarctions and AD pathology, controlling for age, sex, and education.

Results: AD pathology was related to all five cognitive domains (p < 0.01) and infarctions were related to perceptual speed (p < 0.001). Diabetes (present in 15% subjects) was associated with an increased odds of infarction (OR = 2.47, 95% CI: 1.16, 5.24). Diabetes was not related to global AD pathology score, or to specific measures of neuritic plaques, diffuse plaques or tangles, or to amyloid burden or tangle density.

Conclusion: We found a relation between diabetes and cerebral infarction but not between diabetes and Alzheimer disease pathology in older persons.


Supported by National Institute on Aging grants K23 AG23675 (Z.A.), K08 AG00849 (J.A.S.), P30 AG10161 (D.A.B.), and R01 AG15819 (D.A.B.).

Disclosure: The authors report no conflicts of interest.

Received February 23, 2006. Accepted in final form August 22, 2006.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
J. S. Saczynski, M. K. Jonsdottir, M. E. Garcia, P. V. Jonsson, R. Peila, G. Eiriksdottir, E. Olafsdottir, T. B. Harris, V. Gudnason, and L. J. Launer
Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
Am. J. Epidemiol., November 15, 2008; 168(10): 1132 - 1139.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. S. Beeri, J. Schmeidler, J. M. Silverman, S. Gandy, M. Wysocki, C. M. Hannigan, D. P. Purohit, G. Lesser, H. T. Grossman, and V. Haroutunian
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
Neurology, September 2, 2008; 71(10): 750 - 757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.